259 related articles for article (PubMed ID: 7955581)
1. Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study.
Valeri A; Radhakrishnan J; Estes D; D'Agati V; Kopelman R; Pernis A; Flis R; Pirani C; Appel GB
Clin Nephrol; 1994 Aug; 42(2):71-8. PubMed ID: 7955581
[TBL] [Abstract][Full Text] [Related]
2. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.
Conlon PJ; Fischer CA; Levesque MC; Smith SR; St Clair EW; Allen NB; Fleming JA; Howell DN
Clin Nephrol; 1996 Sep; 46(3):170-5. PubMed ID: 8879851
[TBL] [Abstract][Full Text] [Related]
3. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
Shen K; Yu Y; Tang Z; Liu Z; Li L
Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
[TBL] [Abstract][Full Text] [Related]
4. Lupus nephritis in children--a review of 167 patients.
Yang LY; Chen WP; Lin CY
Pediatrics; 1994 Sep; 94(3):335-40. PubMed ID: 8065859
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
Faedda R; Palomba D; Satta A; Pirisi M; Tanda F; Bartoli E
Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of the diffuse and focal proliferative forms of lupus nephropathy with intravenous cyclophosphamide. Intravenous cyclophosphamide in systemic lupus erythematosus].
Vigil A; Gallar P; Oliet A; Ortega O; Bajo MA
Rev Clin Esp; 1995 Aug; 195(8):524-9. PubMed ID: 7569197
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporine treatment of lupus membranous nephropathy.
Radhakrishnan J; Kunis CL; D'Agati V; Appel GB
Clin Nephrol; 1994 Sep; 42(3):147-54. PubMed ID: 7994932
[TBL] [Abstract][Full Text] [Related]
8. Intravenous pulse cyclophosphamide in the treatment of type IV lupus nephritis.
Eiser AR; Grishman E; Dreznin S
Clin Nephrol; 1993 Sep; 40(3):155-9. PubMed ID: 8403570
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors of diffuse proliferative lupus nephritis.
Lim CS; Chin HJ; Jung YC; Kim YS; Ahn C; Han JS; Kim S; Lee JS
Clin Nephrol; 1999 Sep; 52(3):139-47. PubMed ID: 10499308
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of acute systemic lupus erythematosus with intravenous infusions of cyclophosphamide. Value and limitations].
De Bandt M; Goycochea MV; Meyer O; Delahousse M; Palazzo E; M'Bappé P; Kahn MF
Ann Med Interne (Paris); 1994; 145(2):75-87. PubMed ID: 8024184
[TBL] [Abstract][Full Text] [Related]
11. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs.
Austin HA; Klippel JH; Balow JE; le Riche NG; Steinberg AD; Plotz PH; Decker JL
N Engl J Med; 1986 Mar; 314(10):614-9. PubMed ID: 3511372
[TBL] [Abstract][Full Text] [Related]
12. Long-term prognosis of diffuse lupus nephritis.
Ponticelli C; Zucchelli P; Moroni G; Cagnoli L; Banfi G; Pasquali S
Clin Nephrol; 1987 Dec; 28(6):263-71. PubMed ID: 3327639
[TBL] [Abstract][Full Text] [Related]
13. Lupus nephritis: a 13-year experience.
Walker RJ; Bailey RR; Swainson CP; Lynn KL
N Z Med J; 1986 Nov; 99(814):894-6. PubMed ID: 3468414
[TBL] [Abstract][Full Text] [Related]
14. Lupus nephritis: prognostic factors in children.
McCurdy DK; Lehman TJ; Bernstein B; Hanson V; King KK; Nadorra R; Landing BH
Pediatrics; 1992 Feb; 89(2):240-6. PubMed ID: 1734390
[TBL] [Abstract][Full Text] [Related]
15. Response to treatment as a predictor of longterm outcome in patients with lupus nephritis.
Fraenkel L; MacKenzie T; Joseph L; Kashgarian M; Hayslett JP; Esdaile JM
J Rheumatol; 1994 Nov; 21(11):2052-7. PubMed ID: 7869309
[TBL] [Abstract][Full Text] [Related]
16. [Cyclophosphamide bolus therapy in lupus nephritis].
Witte T; Schaumann D; Hein R; Helmchen U; Neumann KH; Koch KM; Deicher H; Schmidt RE
Dtsch Med Wochenschr; 1993 Jul; 118(27-28):1005-10. PubMed ID: 8334946
[TBL] [Abstract][Full Text] [Related]
17. [Effect of methylprednisolone pulse therapy in patients with lupus nephritis assessed by WHO morphologic classification].
Makino H; Yamasaki Y; Hayashi Y; Haramoto T; Shikata K; Kumagai I; Taniai K; Takahashi K; Ota Z
Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):791-9. PubMed ID: 2273595
[TBL] [Abstract][Full Text] [Related]
18. The course and treatment of lupus nephritis.
Appel GB; Valeri A
Annu Rev Med; 1994; 45():525-37. PubMed ID: 8198400
[TBL] [Abstract][Full Text] [Related]
19. Intravenous cyclophosphamide pulse therapy on children with severe active lupus nephritis.
Yan DC; Chou CC; Tsai MJ; Chiang BL; Tsau YK; Hsieh KH
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(3):203-9. PubMed ID: 7618472
[TBL] [Abstract][Full Text] [Related]
20. The benefit of early treatment with immunosuppressive agents in lupus nephritis.
Esdaile JM; Joseph L; MacKenzie T; Kashgarian M; Hayslett JP
J Rheumatol; 1994 Nov; 21(11):2046-51. PubMed ID: 7869308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
